$CMPS

COMPASS Pathways plc

1
0
0

No SEC Form 4 filings for $CMPS in the last 30 days.

Low

Compass Pathfinder Limited: Compass Pathways Elects Kathleen Tregoning to Board of Directors

Compass Pathways (Nasdaq: CMPS) said it elected Kathleen Tregoning to its Board of Directors at its annual general meeting. She will serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee, according to the company. Tregoning previously led corporate affairs and commercial strategy at Cerevel Therapeutics and held external affairs roles at Sanofi and Biogen.

Compass Pathways investors can hear management live online April 14

Compass Pathways plc announced that its management will attend the Needham Virtual Healthcare Conference on April 14, 2026. They will participate in a fireside chat at 12:45 pm ET, with a live audio webcast available on the Investors section of the company's website. Compass Pathways is a biotechnology company focused on mental health, developing investigational COMP360 synthetic psilocybin treatment for conditions like treatment-resistant depression.

News on $CMPS